BioWorld - Sunday, December 14, 2025

BioWorld Science

Feb. 13, 2017

View Archived Issues

AVEO Oncology reports clinical, regulatory progress with tivozanib

Read More

Cellceutix initiates main clinical site for phase IIa trial of Kevetrin

Read More

Hybrigenics presents preliminary results of phase II trial of inecalcitol in patients with CML

Read More

Phase I/II results for VM-202 in subjects with amyotrophic lateral sclerosis

Read More

Seattle Genetics and Immunomedics enter global license agreement for sacituzumab govitecan

Read More

Two-year data for trans-sodium crocetinate plus temozolomide and RT in glioblastoma multiforme

Read More

Merck Sharp & Dohme begins phase I testing of MK-1454 in advanced solid tumors, lymphomas

Read More

New autism research center established at MIT

Read More

Reckitt Benckiser to acquire Mead Johnson Nutrition

Read More

Alexo initiates phase I testing of ALX-148

Read More

Hutchison MediPharma initiates first-in-human study of HMPL-453

Read More

Cancer Research UK announces the first recipients of its global Grand Challenge competition

Read More

MMJ PhytoTech announces phase II study of PTL-101 to treat refractory epilepsy in children

Read More

TP53 gene mutations linked to lower survival after stem cell transplant for myelodysplastic syndrome

Read More

Novartis files for Japanese approval of Tasigna in pediatric CML

Read More

Acacia reports results from final pivotal trial of Baremsis for rescue treatment of PONV

Read More

STADA Arzneimittel confirms expressions of interest in company

Read More

Furaprevir phase II study completed successfully in Taiwan

Read More

GlaxoSmithKline reflects on highlights of fourth quarter 2016

Read More